Back

Impact of cardiac resynchronisation therapy on patient-reported health status: a prospective real-world Kansas City Cardiomyopathy Questionnaire study

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment (3) Cardiac Resynchronisation Therapy (CRT) Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Margarida Camara Farinha

Hospital Divino Espirito Santo, Ponta Delgada (Portugal)

7 More presentations in this session

Presentation thumbnail
True versus LBBB-like patterns: differential remodeling and outcomes following CRT
Doctor J. Simoes De Azevedo Massa Pereira (Faro, PT)
Abstract
Presentation thumbnail
Sex differences in response to cardiac resynchronization therapy: the role of relative dyssynchrony - Does size matter in sex?
Miss L. van Pelt (Rotterdam, NL)
Abstract
Presentation thumbnail
New left ventricular thrombus during temporary percutaneous microaxial left ventricular assist device support: cumulative incidence, device management, and anticoagulation control
Doctor S. Singh (Hartford, US)
Abstract
Presentation thumbnail
Prognostic value of the surprise question in HeartMate 3 patients
Doctor I. Santos (Ponta Delgada, PT)
Abstract
Presentation thumbnail
Driveline infection burden, management and prognosis in patients under durable LVAD support: a single-center experience with HeartMate 3
Doctor I. Santos (Ponta Delgada, PT)
Abstract

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment (3)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Personalised approaches to devices in heart failure
thumbnail
Congress Presentation
Insights from CRT explantation in a tertiary cardiology centre - infective endocarditis associated with poor outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources